Anglo-Saxon, Norse and Celtic

Anglo-Saxon, Norse and Celtic

Give online
to Anglo-Saxon, Norse and Celtic

  • Anglo Saxon brooch after conservation
    Anglo Saxon brooch

The fields of study covered by the Department of Anglo-Saxon, Norse and Celtic (ASNC) are: Anglo-Saxon England, Scandinavia in the Viking Age, the Brittonic-speaking peoples (Brittany, Cornwall, Wales, Pictish Kingdoms and northern British Kingdoms) and the Gaelic-speaking peoples (Ireland, the Isle of Man and western Scotland).

We also study five vernacular language and literature subjects: Old English, Old Norse, Medieval Welsh, Medieval Irish and Insular Latin. The study of insular manuscripts using palaeography and codicology is also offered to our undergraduate and graduates students.

Find out more

Anglo-Saxon, Norse and Celtic website

Gift announcements

Cambridge owes its world-leading excellence in research and teaching to the generosity of its supporters. Our history is synonymous with a history of far-sighted benefaction, and the same is as true today as it has ever been.

Gift announcement
LycaHealth, the new healthcare brand, have presented a donation of £150,000 to Cambridge University to support Sri Lankan students and improve public health in Sri Lanka.   
Gift announcement
Multi-million pound legacy to create a new 'Ray and Dagmar Dolby Court' at Pembroke College

Impact of giving

Philanthropic giving is at the heart of the success of the Collegiate University, enabling us to make discoveries that change the world and to ensure that our students received an unrivalled education.

Wolfson Laser Lab
Philanthropic impact story
In 2016 the Department of Chemical Engineering and Biotechnology will bid farewell to central Cambridge and move into its new £60m purpose-built home on the West Cambridge Science and Technology Campus.
The new Laboratory of Molecular Biology at Addenbrooke's hospital
Philanthropic impact story
At any one time, more than 1000 clinical trials are being conducted across the Cambridge Biomedical Campus, the largest gathering of clinical, pharmaceutical and biomedical research specialists in Europe. These trials are a crucial step in the design of new medicines and medical devices – translating ideas that started in a research laboratory into new treatments for patients.